A Phase III Study of SI-6603 in Patients with Lumbar Disc Herniation

A Phase III Study of SI-6603 in Patients with Lumbar Disc Herniation - A Phase III Study of SI-6603 in Patients with Lumbar Disc Herniation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007239

Enrollment

160

Registered

2012-02-08

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation

Interventions

SI-6603 Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with lumbar disc herniation 2.Patients whose lumbar disc herniation failed to improve even after pharmacotherapy

Exclusion criteria

Exclusion criteria: 1.Patients who have undergone lumbar operation in the past 2.Patients with diseases that can affect the results of this study

Design outcomes

Primary

Measure	Time frame
Change from baseline of pain due to lumbar disc herniation	—

Countries

Japan

Contacts

Public ContactTaiichi Shirogane

SEIKAGAKU CORPORATION Research & Development Div. Clinical Development Dept.

taiichi.shirogane@seikagaku.co.jp03-5220-8593

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026